Keyphrases
Economic Evaluation
100%
Platelet Function
100%
Cerebrovascular Disease
100%
Review Evaluation
100%
Prognostic Utility
100%
Established Cardiovascular Disease
100%
Aspirin Resistance
100%
Platelet Function Tests
100%
Aspirin
61%
Clinical Heterogeneity
23%
Methodological Heterogeneity
23%
Adverse Clinical Outcomes
15%
Cost-effectiveness
15%
Economic Model
15%
Clinical Events
15%
Prognostic Effect
15%
Aspirin Therapy
15%
National Institute for Health Research
7%
Clinical Outcomes
7%
High Risk
7%
Therapy Strategy
7%
Clinical Efficacy
7%
Adjusted Odds Ratio
7%
Prognostic Value
7%
MEDLINE
7%
Meta-analysis
7%
Monotherapy
7%
Embase
7%
Evidence-based
7%
Prognostic Factors
7%
Health Technology Assessment
7%
Measurement Method
7%
Inconsistency
7%
Large Volume
7%
Cost-effectiveness Analysis
7%
Cardiovascular Events
7%
Cost Study
7%
Adjusted Hazard Ratio
7%
Platelet Activity
7%
Antiplatelet Therapy
7%
Patients at Risk
7%
Prognostic Model
7%
Secondary Prevention of Cardiovascular Diseases
7%
Prospero
7%
Prognostic Study
7%
Assessment Programs
7%
Ongoing Trials
7%
Clinical Costs
7%
Conference Proceedings
7%
Economic Modeling
7%
Bibliographic Databases
7%
Individual Patient Data
7%
Standardized Method
7%
Diagnostic Study
7%
Systematic Review Methods
7%
Trial Registries
7%
Function Change
7%
Level Effect
7%
Treatment Modification
7%
Prognostic Ability
7%
Risk of Bias Assessment
7%
Incomplete Reporting
7%
Adverse Clinical Events
7%
Individual Risk Prediction
7%
Exploratory Modelling
7%
Medicine and Dentistry
Systematic Review
100%
Cardiovascular Disease
100%
Acetylsalicylic Acid
100%
Thrombocyte Function
100%
Cerebrovascular Disease
100%
Function Test
86%
Cost-Effectiveness Analysis
20%
Health Care Cost
13%
Platelet
6%
Cardiovascular System
6%
Odds Ratio
6%
Hazard Ratio
6%
Monotherapy
6%
Effect Size
6%
Meta-Analysis
6%
Prognostic Factor
6%
Technology Assessment
6%
Health Technology
6%
Diagnosis
6%
Patient-Data
6%
Secondary Prevention
6%
Antiplatelet
6%
Checklist
6%
Nursing and Health Professions
Systematic Review
100%
Cardiovascular Disease
100%
Economic Evaluation
100%
Cerebrovascular Disease
100%
Blood Clotting Parameters
100%
Clinical Outcome
23%
Cost Effectiveness Analysis
23%
Clinical Effectiveness
7%
Hazard Ratio
7%
Meta Analysis
7%
Biomedical Technology Assessment
7%
Checklist
7%
Diagnosis
7%
Patient Coding
7%
Effect Size
7%
Secondary Prevention
7%
Bibliographic Database
7%
Monotherapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
100%
Acetylsalicylic Acid
100%
Cerebrovascular Disease
100%
Monotherapy
6%
Antiplatelet
6%
Biochemistry, Genetics and Molecular Biology
Thrombocyte Function
100%
Platelet
6%
Patient Coding
6%
Bibliographic Database
6%